Immunoprotein Diagnostic Testing Market Analysis By Type (Complement System Proteins, Free Light Chain, Haptoglobin, Immunoglobulin, Prealbumin, CRP Diagnostic Tests), By Technology, By Application, And Segment Forecasts, 2014 - 2025

Published: Jul, 2017 | Pages: 112 | Publisher: Grand View Research
Industry: Biotechnology | Report Format: Electronic (PDF)

The global immunoprotein diagnostic testing market is anticipated to reach USD 10.3 billion by 2025, according to a new report by Grand View Research, Inc. This growth can be attributed to the rising incidence of chronic diseases.
According to American Heart Association's 2017 statistics, nearly 790,000 people experience heart attack every year in the U.S. In addition, stroke is responsible for 1 in every 20 deaths in the U.S. Hence, WHO is also taking initiatives to reduce the risk of cardiovascular diseases. As a result of the aforementioned factors, the demand for immunoprotein diagnostics is expected to rise in order to facilitate rapid diagnosis.
According to WHO, nearly 1.69 million deaths due to lung cancer were registered in 2015 throughout the world. Hence, fast and accurate diagnosis of such chronic diseases has become important to reduce the high mortality rate. Immunoprotein diagnostic devices and reagents have proved to be highly effective in rapidly detecting chronic diseases.
Technological advancements in the field of immunoprotein diagnostics have led to introduction of novel products. For instance, LIAISON XL, manufactured by DiaSorin, is a fully automated chemiluminescence analyzer that facilitates complete sample processing. It also measures and evaluates testing samples, thereby, enhancing the efficiency and throughput of the system.
Further Key Findings From the Study Suggest:
• In 2016, immunoglobulin tests dominated the market owing to their frequent usage by healthcare professionals for diagnosing infectious or autoimmune disorders
• C-Reactive Protein (CRP) tests held a significant market share in 2016 due to the broad product portfolio of these assays and reagents
• Infectious disease testing held largest market share in 2016 owing to the increasing prevalence of infectious diseases and high applications of immunoprotein tests
• Enzyme-based immunoassays dominated the market in 2016 due to their frequent usage and availability of large number of products that possess this technology
• Chemiluminescence assay is anticipated to witness highest growth over the forecast period due to its high sensitivity and specificity
• North America dominated the market in 2016 due to rising prevalence of cancer & increase in mortality due to cancer-related diseases and favorable healthcare reimbursement scenario in the U.S.
• Some of the key players are Bio-Rad Laboratories, Inc.; F. Hoffmann-La Roche AG; Abbott Laboratories; Enzo Biochem, Inc.; Thermo Fisher Scientific, Inc.; DiaSorin S.p.A; bioMerieux SA; and Siemens Healthcare GmbH

 Table of Contents

Chapter 1 Research Methodology
               1.1 Country Wise Market: Base Estimates
               1.2 Global Market: CAGR Calculation
               1.3 Region Based Segment Share Calculation
               1.4 Research Scope & Assumptions
               1.5 List of Data Sources
                   1.5.1 Data for primary interviews, by sources
                   1.5.2 Data for primary interviews, by region
Chapter 2 Executive Summary
               2.1 Market Snapshot
Chapter 3 Immunoprotein Diagnostics Market Variables, Trends & Scope
               3.1 Market Segmentation & Scope
               3.2 Market Driver Analysis
                   3.2.1 Rising prevalence of chronic diseases
                   3.2.2 Increase in technological advancements
               3.3 Market Restraint Analysis
                   3.3.1 Availability of alternative infectious disease testing approaches
               3.4 Key Opportunities Prioritized
                   3.4.1 Key opportunities prioritized, by test type
                   3.4.2 Key opportunities prioritized, by application
                   3.4.3 Key opportunities prioritized, by technology
               3.5 Immunoprotein Diagnostics - SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
               3.6 Industry Analysis - Porter's
               3.7 Immunoprotein Diagnostics Market: Market Position Analysis, 2016
Chapter 4 Immunoprotein Diagnostics Market: Test Type Estimates & Trend Analysis
               4.1 Immunoprotein Diagnostics Market: Test Type Movement Analysis
               4.2 Immunoglobulin Diagnostic Tests
                   4.2.1 Immunoglobulin diagnostic tests market, 2014 - 2025 (USD Million)
               4.3 C-Reactive Protein (CRP) Diagnostic Tests
                   4.3.1 CRP market, 2014 - 2025 (USD Million)
               4.4 Free Light Chain Diagnostic Tests
                   4.4.1 Free light chain diagnostic tests market, 2014 - 2025 (USD Million)
               4.5 Complement System Proteins Diagnostic Tests
                   4.5.1 Complement system protein tests market, 2014 - 2025 (USD Million)
               4.6 Haptoglobin Diagnostic Tests
                   4.6.1 Haptoglobin diagnostic test market, 2014 - 2025 (USD Million)
               4.7 Prealbumin Diagnostic Tests
                   4.7.1 Prealbumin diagnostic tests market, 2014 - 2025 (USD Million)
Chapter 5 Immunoprotein Diagnostics Market: Application Estimates & Trend Analysis
               5.1 Immunoprotein Diagnostics Market: Application Movement Analysis
               5.2 Infectious Disease Testing
                   5.2.1 Infectious disease testing market, 2014 - 2025 (USD Million)
               5.3 Oncology Testing
                   5.3.1 Oncology testing market, 2014 - 2025 (USD Million)
               5.4 Endocrine Testing
                   5.4.1 Endocrine testing market, 2014 - 2025 (USD Million)
               5.5 Autoimmune Disease Testing
                   5.5.1 Autoimmune disease testing market, 2014 - 2025 (USD Million)
               5.6 Allergy Testing
                   5.6.1 Allergy testing market, 2014 - 2025 (USD Million)
               5.7 Toxicology Testing
                   5.7.1 Toxicology testing market, 2014 - 2025 (USD Million)
Chapter 6 Immunoprotein Diagnostics Market: Technology Estimates & Trend Analysis
               6.1 Immunoprotein Diagnostics Market: Technology Movement Analysis
               6.2 Enzyme Based Immunoassay
                   6.2.1 Enzyme based immunoassay market, 2014 - 2025 (USD Million)
               6.3 Immunoprotein Electrophoresis
                   6.3.1 Immunoprotein electrophoresis market, 2014 - 2025 (USD Million)
               6.4 Chemiluminescence Assay
                   6.4.1 Chemiluminescence assay market, 2014 - 2025 (USD Million)
               6.5 Immunofluorescence Assay
                   6.5.1 Immunofluorescence assay market, 2014 - 2025 (USD Million)
               6.6 Radioimmunoassay
                   6.6.1 Radioimmunoassay market, 2014 - 2025 (USD Million)
               6.7 Immunoturbidity Assay
                   6.7.1 Immunoturbidity assay market, 2014 - 2025 (USD Million)
Chapter 7 Immunoprotein Diagnostics Market: Regional Estimates & Trend Analysis, by Test Type, Application, Technology
               7.1 Immunoprotein Diagnostics Market Share by Region, 2014 & 2025
               7.2 North America
                   7.2.1 U.S.
                   7.2.2 Canada
               7.3 Europe
                   7.3.1 Germany
                   7.3.2 UK
                   7.3.3 France
                   7.3.4 Italy
                   7.3.5 Spain
               7.4 Asia Pacific
                   7.4.1 Japan
                   7.4.2 China
                   7.4.3 India
               7.5 Latin America
                   7.5.1 Brazil
                   7.5.2 Mexico
               7.6 MEA
                   7.6.1 South Africa
                   7.6.2 Saudi Arabia
Chapter 8 Competitive Landscape
               8.1 Company Profiles
                   8.1.1 Abbott Laboratories
                       8.1.1.1 Company Overview
                       8.1.1.2 Financial Performance
                       8.1.1.3 Product Benchmarking
                   8.1.2 Abcam Plc
                       8.1.2.1 Company Overview
                       8.1.2.2 Financial Performance
                       8.1.2.3 Product Benchmarking
                       8.1.2.4 Strategic initiatives
                   8.1.3 Bio-Rad Laboratories, Inc.
                       8.1.3.1 Company Overview
                       8.1.3.2 Financial Performance
                       8.1.3.3 Product Benchmarking
                       8.1.3.4 Strategic Initiatives
                   8.1.4 Beckman Coulter, Inc.
                       8.1.4.1 Company Overview
                       8.1.4.2 Product Benchmarking
                       8.1.4.3 Strategic Initiatives
                   8.1.5 Diasorin S.P.A
                       8.1.5.1 Company Overview
                       8.1.5.2 Financial Performance
                       8.1.5.3 Product Benchmarking
                       8.1.5.4 Strategic Initiatives
                   8.1.6 Enzo Biochem, Inc.
                       8.1.6.1 Company Overview
                       8.1.6.2 Financial Performance
                       8.1.6.3 Product Benchmarking
                   8.1.7 F. Hoffmann-La Roche Ag
                       8.1.7.1 Company Overview
                       8.1.7.2 Financial Performance
                       8.1.7.3 Product Benchmarking
                       8.1.7.4 Strategic Initiatives
                   8.1.8 Ortho Clinical Diagnostics
                       8.1.8.1 Company Overview
                       8.1.8.2 Product Benchmarking
                       8.1.8.3 Strategic Initiatives
                   8.1.9 Siemens Healthcare GmbH
                       8.1.9.1 Company Overview
                       8.1.9.2 Financial Performance
                       8.1.9.3 Product Benchmarking
                       8.1.9.4 Strategic Initiatives
                   8.1.10 Thermo Fisher Scientific Inc
                       8.1.10.1 Company Overview
                       8.1.10.2 Financial Performance
                       8.1.10.3 Product Benchmarking
                   8.1.11 bioMerieux SA
                       8.1.11.1 Company Overview
                       8.1.11.2 Financial Performance
                       8.1.11.3 Product Benchmarking

List of Tables

TABLE 1 Factors used in segment share estimation
TABLE 2 List of secondary data sources
TABLE 3 North America immunoprotein diagnostics market, by country, 2014 - 2025 (USD Million)
TABLE 4 North America immunoprotein diagnostics market, by test type, 2014 - 2025 (USD Million)
TABLE 5 North America immunoprotein diagnostics, by application, 2014 - 2025 (USD Million)
TABLE 6 North America immunoprotein diagnostics market, by technology, 2014 - 2025 (USD Million)
TABLE 7 U.S. immunoprotein diagnostics market, by test type, 2014 - 2025 (USD Million)
TABLE 8 U.S. immunoprotein diagnostics, by application, 2014 - 2025 (USD Million)
TABLE 9 U.S. immunoprotein diagnostics market, by technology, 2014 - 2025 (USD Million)
TABLE 10 Canada immunoprotein diagnostics market, by test type, 2014 - 2025 (USD Million)
TABLE 11 Canada immunoprotein diagnostics, by application, 2014 - 2025 (USD Million)
TABLE 12 Canada immunoprotein diagnostics market, by technology, 2014 - 2025 (USD Million)
TABLE 13 Europe immunoprotein diagnostics market, by country, 2014 - 2025 (USD Million)
TABLE 14 Europe immunoprotein diagnostics market, by test type, 2014 - 2025 (USD Million)
TABLE 15 Europe immunoprotein diagnostics, by application, 2014 - 2025 (USD Million)
TABLE 16 Europe immunoprotein diagnostics market, by technology, 2014 - 2025 (USD Million)
TABLE 17 Germany immunoprotein diagnostics market, by test type, 2014 - 2025 (USD Million)
TABLE 18 Germany immunoprotein diagnostics, by application, 2014 - 2025 (USD Million)
TABLE 19 Germany immunoprotein diagnostics market, by technology, 2014 - 2025 (USD Million)
TABLE 20 UK immunoprotein diagnostics market, by test type, 2014 - 2025 (USD Million)
TABLE 21 UK immunoprotein diagnostics, by application, 2014 - 2025 (USD Million)
TABLE 22 UK immunoprotein diagnostics market, by technology, 2014 - 2025 (USD Million)
TABLE 23 France immunoprotein diagnostics market, by test type, 2014 - 2025 (USD Million)
TABLE 24 France immunoprotein diagnostics, by application, 2014 - 2025 (USD Million)
TABLE 25 France immunoprotein diagnostics market, by technology, 2014 - 2025 (USD Million)
TABLE 26 Italy immunoprotein diagnostics market, by test type, 2014 - 2025 (USD Million)
TABLE 27 Italy immunoprotein diagnostics, by application, 2014 - 2025 (USD Million)
TABLE 28 Italy immunoprotein diagnostics market, by technology, 2014 - 2025 (USD Million)
TABLE 29 Spain immunoprotein diagnostics market, by test type, 2014 - 2025 (USD Million)
TABLE 30 Spain immunoprotein diagnostics, by application, 2014 - 2025 (USD Million)
TABLE 31 Spain immunoprotein diagnostics market, by technology, 2014 - 2025 (USD Million)
TABLE 32 Asia Pacific immunoprotein diagnostics market, by country, 2014 - 2025 (USD Million)
TABLE 33 Asia Pacific immunoprotein diagnostics market, by test type, 2014 - 2025 (USD Million)
TABLE 34 Asia Pacific immunoprotein diagnostics, by application, 2014 - 2025 (USD Million)
TABLE 35 Asia Pacific immunoprotein diagnostics market, by technology, 2014 - 2025 (USD Million)
TABLE 36 Japan immunoprotein diagnostics market, by test type, 2014 - 2025 (USD Million)
TABLE 37 Japan immunoprotein diagnostics, by application, 2014 - 2025 (USD Million)
TABLE 38 Japan immunoprotein diagnostics market, by technology, 2014 - 2025 (USD Million)
TABLE 39 China immunoprotein diagnostics market, by test type, 2014 - 2025 (USD Million)
TABLE 40 China immunoprotein diagnostics, by application, 2014 - 2025 (USD Million)
TABLE 41 China immunoprotein diagnostics market, by technology, 2014 - 2025 (USD Million)
TABLE 42 India immunoprotein diagnostics market, by test type, 2014 - 2025 (USD Million)
TABLE 43 India immunoprotein diagnostics, by application, 2014 - 2025 (USD Million)
TABLE 44 India immunoprotein diagnostics market, by technology, 2014 - 2025 (USD Million)
TABLE 45 Latin America immunoprotein diagnostics market, by country, 2014 - 2025 (USD Million)
TABLE 46 Latin America immunoprotein diagnostics market, by test type, 2014 - 2025 (USD Million)
TABLE 47 Latin America immunoprotein diagnostics, by application, 2014 - 2025 (USD Million)
TABLE 48 Latin America immunoprotein diagnostics market, by technology, 2014 - 2025 (USD Million)
TABLE 49 Brazil immunoprotein diagnostics market, by test type, 2014 - 2025 (USD Million)
TABLE 50 Brazil immunoprotein diagnostics, by application, 2014 - 2025 (USD Million)
TABLE 51 Brazil immunoprotein diagnostics market, by technology, 2014 - 2025 (USD Million)
TABLE 52 Mexico immunoprotein diagnostics market, by test type, 2014 - 2025 (USD Million)
TABLE 53 Mexico immunoprotein diagnostics, by application, 2014 - 2025 (USD Million)
TABLE 54 Mexico immunoprotein diagnostics market, by technology, 2014 - 2025 (USD Million)
TABLE 55 MEA immunoprotein diagnostics market, by country, 2014 - 2025 (USD Million)
TABLE 56 MEA immunoprotein diagnostics market, by test type, 2014 - 2025 (USD Million)
TABLE 57 MEA immunoprotein diagnostics, by application, 2014 - 2025 (USD Million)
TABLE 58 MEA immunoprotein diagnostics market, by technology, 2014 - 2025 (USD Million)
TABLE 59 South Africa immunoprotein diagnostics market, by test type, 2014 - 2025 (USD Million)
TABLE 60 South Africa immunoprotein diagnostics, by application, 2014 - 2025 (USD Million)
TABLE 61 South Africa immunoprotein diagnostics market, by technology, 2014 - 2025 (USD Million)
TABLE 62 Saudi Arabia immunoprotein diagnostics market, by test type, 2014 - 2025 (USD Million)
TABLE 63 Saudi Arabia immunoprotein diagnostics, by application, 2014 - 2025 (USD Million)
TABLE 64 Saudi Arabia immunoprotein diagnostics market, by technology, 2014 - 2025 (USD Million)